Cargando…

“Impact of pentaglobin in severe COVID 19 pneumonia- a prospective study.”

BACKGROUND: The current COVID-19 pandemic has become a global public health crisis and presents a serious challenge in treatment of severe COVID pneumonia patients. With an imperative need for an effective treatment, we aimed to study the effectiveness of Pentaglobin, an intravenous immunoglobin in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Dinesh, Sharma, Kamal, Thangasami, Senthilraj, Patel, Rahul, Patel, Iva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270756/ https://www.ncbi.nlm.nih.gov/pubmed/34304002 http://dx.doi.org/10.1016/j.intimp.2021.107968

Ejemplares similares

The Role of IgM-Enriched Immunoglobulin (Pentaglobin) in Septic Patients with Hematological Disease
por: Fernandes, Pedro Amoedo, et al.
Publicado: (2021)

IgM-enriched immunoglobulins (Pentaglobin) may improve the microcirculation in sepsis: a pilot randomized trial
por: Domizi, Roberta, et al.
Publicado: (2019)

Pentaglobin (immunoglobulin M-enriched immunoglobulin) as adjuvant therapy for premature and very low-birth-weight neonates with sepsis
por: Nassir, Kawthar F., et al.
Publicado: (2021)

A human IgM enriched immunoglobulin preparation, Pentaglobin, reverses autoimmune diabetes without immune suppression in NOD mice
por: Wilson, Christopher S., et al.
Publicado: (2022)

Pentaglobin(®) Efficacy in Reducing the Incidence of Sepsis and Transplant-Related Mortality in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Study
por: Giorgia, Carlone, et al.
Publicado: (2020)

The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis
por: Cui, Jie, et al.
Publicado: (2019)

Does the extent of collaterals influence the severity of the myocardial injury as assessed by elevation in biomarkers?
por: Dubey, Gajendra, et al.
Publicado: (2021)

Impact of high dose of baricitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangladesh
por: Hasan, Md. Jahidul, et al.
Publicado: (2021)

CORTICOSTEROID TREATMENT IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA
por: Hong, Gloria, et al.
Publicado: (2020)

COVID-19 Coronavirus-Induced Atypical Pneumonia: Efficacy of the Monoclonal Antibody Bevacizumab in Moderate to Severe Cases
por: Patel, Greshaben, et al.
Publicado: (2021)

Role of Speckle Tracking Echocardiography to Predict Left Ventricular Dysfunction Post Mitral Valve Replacement Surgery for Severe Mitral Regurgitation
por: Shanishwara, Parth, et al.
Publicado: (2022)

Cutaneous Mucormycosis in a Patient of Severe COVID-19 Pneumonia: A Rarer than Rare Case Report
por: Tambe, Rahul R, et al.
Publicado: (2021)

Challenges in Steroid and Anticoagulant Therapy in Severe COVID-19 Pneumonia: A Prospective Study
por: Hassan, Alaa Thabet, et al.
Publicado: (2021)

How does clinical profile and outcome differ in patients with Chronic Kidney Disease undergoing percutaneous coronary revascularization according to the severity of CKD? – CHANNEL Study
por: Jayesh, Meniya, et al.
Publicado: (2021)

Otorrhea as a Resolution for a Parotid Abscess through an Unusual Natural Pathway: A Case Report and Recent Literature Review
por: Zazali, Suhaili, et al.
Publicado: (2022)

Nasopharyngeal microbiome of COVID-19 patients revealed a distinct bacterial profile in deceased and recovered individuals
por: Kumar, Dinesh, et al.
Publicado: (2022)

Clostridioides difficile and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia
por: Bogdanová, Kateřina, et al.
Publicado: (2021)

A Case of Hemolytic Anemia With Acute Myocarditis and Cardiogenic Shock: A Rare Presentation of COVID-19
por: Singhavi, Ravi, et al.
Publicado: (2020)

A Case Series of Secondary Spontaneous Pneumomediastinum and Pneumothorax in Severe COVID-19 Pneumonia
por: Staiano, Peter P, et al.
Publicado: (2022)

Comorbidities associated with the severity of COVID-19, and differences across ethnic groups: a UK Biobank cohort study
por: Patel, Rahul, et al.
Publicado: (2023)

Risk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study
por: Zhang, Nannan, et al.
Publicado: (2021)

Does serum butyrylcholinesterase level determine the severity and mortality of COVID-19 pneumonia?: Prospective study
por: Sipahioglu, Hilal, et al.
Publicado: (2022)

Provision of holistic care after severe COVID-19 pneumonia: anticipating clinical need and managing resources
por: D'Cruz, Rebecca F, et al.
Publicado: (2020)

Mucormycosis, Diabetes and COVID-19 Pneumonia: Unleashing the Facts
por: Shastri, Minal, et al.
Publicado: (2022)

Incidence and predictors of development of new onset hypertension post COVID-19 disease
por: Vyas, Pooja, et al.
Publicado: (2023)

Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia
por: Bronte, O., et al.
Publicado: (2023)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Pulmonary Embolism in COVID-19 Pneumonia: Random Association or Causality?
por: Fortuzi, Ked, et al.
Publicado: (2020)

Adequate Antithrombin III Level Predicts Survival in Severe COVID-19 Pneumonia
por: Joshi, Deepti, et al.
Publicado: (2021)

Impact of Mediastinal Lymphadenopathy on the Severity of COVID-19 Pneumonia: A Nationwide Multicenter Cohort Study
por: Lee, Jong Eun, et al.
Publicado: (2022)

Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study
por: Lahmer, Tobias, et al.
Publicado: (2021)

Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact?
por: Hasan, Md. Jahidul, et al.
Publicado: (2021)

Effect of Intubation Timing on the Outcome of Patients With Severe Respiratory Distress Secondary to COVID-19 Pneumonia
por: Fayed, Mohamed, et al.
Publicado: (2021)

Prevalence and cross states comparison of case fatality rate and recovery rate of COVID 19/SARS-COV-2 in India
por: Z. Ansari, Ajaz Ahmed, et al.
Publicado: (2021)

Impact of the COVID-19 Lockdown and Confinement Measures on the Musculoskeletal Health of the Urban Geriatric Population
por: Sharma, Siddhartha, et al.
Publicado: (2021)

Microcirculation alterations in severe COVID-19 pneumonia
por: Kanoore Edul, Vanina Siham, et al.
Publicado: (2021)

Severe Hypoxemia in Early COVID-19 Pneumonia
por: Bhatia, Pradeep, et al.
Publicado: (2020)

Imaging changes in severe COVID-19 pneumonia
por: Zhang, Wei
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v0nqroq4m030bn0v19r9dgtb2k